Damora Therapeutics (DMRA) Interest Coverage Ratio (QoQ) (2019 - 2026)
Damora Therapeutics (DMRA) Interest Coverage Ratio (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.99% |
| Dec 31, 2025 | -25,463.50% |
| Sep 30, 2025 | -310.53% |
| Jun 30, 2025 | -30.15% |
| Mar 31, 2025 | 86.28% |
| Dec 31, 2024 | -180.22% |
| Sep 30, 2024 | 33.90% |
| Jun 30, 2024 | -86.19% |
| Mar 31, 2024 | -59.96% |
| Dec 31, 2023 | 45.00% |
| Sep 30, 2023 | -1,969.86% |
| Jun 30, 2023 | 63.67% |
| Mar 31, 2023 | 89.19% |
| Dec 31, 2022 | 14.16% |
| Sep 30, 2022 | 28.75% |
| Jun 30, 2022 | -186.61% |
| Mar 31, 2022 | 59.34% |
| Dec 31, 2021 | -1,850.83% |
| Sep 30, 2021 | -104.62% |
| Jun 30, 2021 | -22.06% |